Evidence map›Paper›PMID 37799497›Full record

ReviewDigital health

Crowdsourcing smartphone data for biomedical research: Ethical and legal questions.

Michael Lang, Kyle McKibbin, Mahsa Shabani, Pascal Borry, Vincent Gautrais, Kamiel Verbeke, Ma'n H Zawati

Abstract readReview
In one paragraph

Review in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael LangFaculty of Medicine and Health Sciences, Centre of Genomics and Policy, McGill University, Montreal, Canada.
Kyle McKibbinFaculty of Law and Criminology, Ghent University, Institute for International Research on Criminal Policy, Ghent, Belgium.
Mahsa ShabaniFaculty of Law and Criminology, Ghent University, Institute for International Research on Criminal Policy, Ghent, Belgium.
Pascal BorryKU Leuven, Centre for Biomedical Ethics and Law, Leuven, Belgium.
Vincent GautraisUniversité de Montréal, Faculté de droit, Chaire L.R. Wilson sur le droit des technologies de l'information et du commerce électronique, Montreal, Canada.
Kamiel VerbekeKU Leuven, Centre for Biomedical Ethics and Law, Leuven, Belgium.
Ma'n H ZawatiFaculty of Medicine and Health Sciences, Centre of Genomics and Policy, McGill University, Montreal, Canada.ORCID https://orcid.org/0000-0002-8905-6259

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of smartphones has greatly increased in the last decade and has revolutionized the way that health data are being collected and shared. Mobile applications leverage the ubiquity and technological sophistication of modern smartphones to record and process a variety of metrics relevant to human health, including behavioral measures, clinical data, and disease symptoms. Information processed by mobile applications may have significant utility for increasing biomedical knowledge, both through conventional research and emerging discovery paradigms such as citizen science. However, the ways in which smartphone-collected data may be used in nontraditional modes of biomedical discovery are not well understood, such as using data to train artificially intelligent algorithms and for product development purposes. This paper argues that the use of mobile health data for algorithm training and product development is (a) likely to become a prominent fixture in medicine, (b) likely to raise significant ethical and legal challenges, and (c) warrants immediate scrutiny by policymakers and scholars. We introduce the concept of "smartphone-crowdsourced medical data," or SCMD, and set out a broad research agenda for addressing concerns associated with this new and potentially momentous practice. We conclude that SCMD for algorithm training raises a number of ethical and legal issues which require further scholarly attention to ensure that individual interests are protected and that emerging health information sources can be used in ways that maximally, and safely, promote medical innovation.

Indexed as

biomedical researchmedical datasmartphone

Identifiers

PMID37799497
PMCPMC10548792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.